S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference|
|Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference|
|Haemonetics Sets Date for Third Quarter Fiscal Year 2015 Earnings Release: January 28, 2015|
|Haemonetics Reports 2nd Quarter Fiscal 2015 Revenue of $228 Million and Adjusted EPS of $0.47; Reaffirms Revenue and Earnings Guidance|
|Salix and Pharming Announce the Launch of RUCONEST® in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)|
|BioCryst Reports Third Quarter 2014 Financial Results|
|BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema|
|Pharming and Salix Announce First Patient Treated in Clinical Study of Ruconest® for Prophylaxis of Hereditary Angioedema|
|BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema|
|Dyax Corp. Announces Expansion of Phase 1b Clinical Trial for DX-2930|
Click above to view more mutual fund data and stats for hae - Haemonetics Corp.